Home > Publications Database > Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy. > print |
001 | 164086 | ||
005 | 20230915090548.0 | ||
024 | 7 | _ | |a 10.1093/infdis/jiac103 |2 doi |
024 | 7 | _ | |a pmid:35313340 |2 pmid |
024 | 7 | _ | |a 0022-1899 |2 ISSN |
024 | 7 | _ | |a 1537-6613 |2 ISSN |
024 | 7 | _ | |a altmetric:125146599 |2 altmetric |
037 | _ | _ | |a DZNE-2022-00749 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a ToVinh, Michael |0 0000-0002-1625-9741 |b 0 |
245 | _ | _ | |a Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy. |
260 | _ | _ | |a Oxford [u.a.] |c 2022 |b Oxford Univ. Press |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1665148524_1935 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a HIV infection is associated with impaired NK cell activity, which is only incompletely restored under antiretroviral therapy. Analysing the bioenergetics profiles of oxygen consumption, we observed several parameters were significantly reduced in HIV(+) NK cells, indicating a mitochondrial defect. Accordingly, we found HIV(+) CD56 bright NK cells to display a decreased mitochondrial membrane potential and mitochondrial mass. Both parameters were positively correlated with IFNγ production of NK cells. Finally, we demonstrated that stimulation of HIV(+) NK cells with MitoTEMPO, mitochondria-targeting antioxidant, significantly improved IFNγ production. In conclusion, we identified mitochondrial dysfunction as a mechanism that contributes to impaired NK cell function. |
536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a HIV |2 Other |
650 | _ | 7 | |a IFNγ |2 Other |
650 | _ | 7 | |a NK cell |2 Other |
650 | _ | 7 | |a immunometabolism |2 Other |
650 | _ | 7 | |a mitochondrial dysfunction |2 Other |
693 | _ | _ | |0 EXP:(DE-2719)IDAF-20190308 |5 EXP:(DE-2719)IDAF-20190308 |e Image and Data Analysis Facility (CRFS-IDAF) / Bonn |x 0 |
700 | 1 | _ | |a Hörr, Gregor |b 1 |
700 | 1 | _ | |a Dobrikova, Kristiyana |b 2 |
700 | 1 | _ | |a Gotter, Christina |b 3 |
700 | 1 | _ | |a Rommel, Clemens |b 4 |
700 | 1 | _ | |a Hoffmeister, Christoph |b 5 |
700 | 1 | _ | |a Raabe, Jan |b 6 |
700 | 1 | _ | |a Kaiser, Kim M |b 7 |
700 | 1 | _ | |a Finnemann, Claudia |b 8 |
700 | 1 | _ | |a Bischoff, Jenny |0 0000-0002-7700-2915 |b 9 |
700 | 1 | _ | |a Rieke, Gereon J |b 10 |
700 | 1 | _ | |a Wilhelm, Christoph |b 11 |
700 | 1 | _ | |a Schmitt, Vanessa |b 12 |
700 | 1 | _ | |a Möhl, Christoph |0 P:(DE-2719)2810422 |b 13 |u dzne |
700 | 1 | _ | |a Aghabeig, Mansoureh |0 P:(DE-2719)2814300 |b 14 |u dzne |
700 | 1 | _ | |a Schwarze-Zander, Carolynne |b 15 |
700 | 1 | _ | |a Boesecke, Christoph |b 16 |
700 | 1 | _ | |a van Bremen, Kathrin |b 17 |
700 | 1 | _ | |a Wasmuth, Jan-Christian |b 18 |
700 | 1 | _ | |a Strassburg, Christian P |b 19 |
700 | 1 | _ | |a Rockstroh, Jürgen K |b 20 |
700 | 1 | _ | |a Spengler, Ulrich |b 21 |
700 | 1 | _ | |a Krämer, Benjamin |b 22 |
700 | 1 | _ | |a Nattermann, Jacob |b 23 |
773 | _ | _ | |a 10.1093/infdis/jiac103 |g p. jiac103 |0 PERI:(DE-600)1473843-0 |n 5 |p 901-906 |t The journal of infectious diseases |v 226 |y 2022 |x 0022-1899 |
909 | C | O | |p VDB |o oai:pub.dzne.de:164086 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2810422 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2814300 |
913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-03 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-03 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-03 |
915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2022-11-25 |w ger |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J INFECT DIS : 2021 |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-25 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-25 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J INFECT DIS : 2021 |d 2022-11-25 |
920 | 1 | _ | |0 I:(DE-2719)1040200 |k IDAF |l Image and Data Analysis (IDAF) |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1040200 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|